Medical device operating metrics: cross-company comparison
Oxford Ledge compares 4 companies on 2 operating metrics extracted from their own SEC earnings exhibits. Every figure below is for Q1 2026. Among 4 companies reporting it for Q1 2026, Boston Scientific Corp. leads on Revenue growth (+9.4%).
Context columns: LTM figures sum the issuer's last four quarterly filings and render blank unless all four quarters are on file. Share price, enterprise value and market cap are not shown here. Market prices are shown to signed-in users.
Metric coverage
Segment revenue: 4 of 4 companies report this on the canonical basis.
Oxford Ledge Signal -- extracted from the issuer's own SEC earnings exhibit and normalized by Oxford Ledge. As reported by the issuer per regulatory convention, not re-audited by us; a figure our extractor could not verify is withheld, never shown. A metric is compared only across companies reporting it on the SAME basis and scope; a blank cell is an honest coverage gap, never a zero, and companies may report different quarters (see the period range). Source: each issuer’s own SEC EDGAR earnings exhibit.
Revenue growth organic / non-GAAP, no reconciliation
+9.4%
+6.6%
+2.4%
+2.9%
Metric coverage
Revenue growth: 4 of 4 companies report this on the canonical basis.
Oxford Ledge Signal -- extracted from the issuer's own SEC earnings exhibit and normalized by Oxford Ledge. As reported by the issuer per regulatory convention, not re-audited by us; a figure our extractor could not verify is withheld, never shown. Every figure in this table is a CHANGE the issuer reported for the period, not a level. Growth rates and levels never share a column or a table -- a change read as a level is a different number entirely. Source: each issuer’s own SEC EDGAR earnings exhibit.
Which medical device company leads on Revenue growth?
Among 4 companies reporting it for Q1 2026, Boston Scientific Corp. leads on Revenue growth (+9.4%).
Where does this data come from?
Each figure is extracted from the company's own SEC earnings exhibit and stamped with its reporting period. A figure is ranked only against companies reporting the same quarter on the same basis; figures are as reported by each issuer and not re-audited by Oxford Ledge. Informational, not investment advice.
